Tuesday, October 15, 2019

Immunic Expands Board

San Diego-based Immunic, a biopharmaceuticals company focused on developing oral therapies for the treatment of chronic inflammatory and autoimmune diseases, has expanded its board, adding Tamar Howson to its board of directors. Howson is currently a director of MEI Pharma, Inc. and Scientus Pharma Inc, and previously served on the board of

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.